Business

Announcement on Voluntary Disclosure of Progress of Down-payment Received for Signing Authorization License and Commercialization Agreement with Intas Pharmaceuticals Ltd. for BAT2506 (Golimumab) Injection

Announcement on Voluntary Disclosure of Progress of Down-payment Received for Signing Authorization License and Commercialization Agreement with Intas Pharmaceuticals Ltd. for BAT2506 (Golimumab) Injection

articleBio-thera Solutions, Ltd. Class AMarch 31, 20255/news/announcement-on-voluntary-disclosure-of-progress-of-down-payment-received-for-signing-authorization-license-and-commercialization-agreement-with-intas-pharmaceuticals-ltd-for-bat2506-golimumab-injection
Announcement on Voluntary Disclosure of Progress of Down-payment Received for Signing Authorization License and Commercialization Agreement with Intas Pharmaceuticals Ltd. for BAT2506 (Golimumab) Injection

About this update from Bio-thera Solutions, Ltd. Class A

Announcement on Voluntary Disclosure of Progress of Down-payment Received for Signing Authorization License and Commercialization Agreement with Intas Pharmaceuticals Ltd. for BAT2506 (Golimumab) InjectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Bio-thera Solutions, Ltd. Class A